Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer
- PMID: 12796672
- DOI: 10.1097/01.ju.0000070963.12496.cc
Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer
Abstract
Purpose: We examined complementary and alternative medicine (CAM) use among men who received standard therapy for localized prostate cancer.
Materials and methods: A total of 417 men completed a questionnaire 6 months after their treatment decision assessing clinical and psychosocial variables and use of 41 available CAM therapies grouped into the 2 general categories of herbal/dietary and nonherbal (i.e. mind-body, bioelectromagnetic, traditional/folk medicine, pharmacological/biological).
Results: The prostate cancer diagnosis prompted 19% of our sample to start using some form of CAM for prostate health, and 67% of men reported having used some form of CAM for prostate health before being diagnosed. Initiation of CAM was associated with being a member of an ethnic minority group and a higher level of education. Initiation of nonherbal CAM was associated with being married, while use of herbal CAM therapies was significantly associated with choosing observation. Herbal use before diagnosis was associated with being white, higher level of education and being single. Prostate specific antigen at diagnosis, Gleason score, quality of life, participant perceptions of seriousness of prostate cancer or self-reported worry about prostate cancer were not related to initiation or prior use. Of those men reporting current use almost 50% did not inform their treating physician of using CAM therapies.
Conclusions: Initiation of CAM therapies as a result of a prostate cancer diagnosis was fairly low, although two-thirds of men had used it before diagnosis. Half of the patients did not inform their physicians about such use and physicians should continue to probe patients about CAM use.
Similar articles
-
A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.Integr Cancer Ther. 2003 Sep;2(3):212-6. doi: 10.1177/1534735403256207. Integr Cancer Ther. 2003. PMID: 15035882
-
Alternative medicine use in patients with localized prostate carcinoma treated with curative intent.Cancer. 1999 Dec 15;86(12):2642-8. Cancer. 1999. PMID: 10594859
-
A prospective study of the use of alternative therapies by men with localized prostate cancer.Patient Educ Couns. 2004 Oct;55(1):70-7. doi: 10.1016/j.pec.2003.07.007. Patient Educ Couns. 2004. PMID: 15476992
-
A literature review of complementary and alternative medicine use by colorectal cancer patients.Complement Ther Clin Pract. 2010 Feb;16(1):52-6. doi: 10.1016/j.ctcp.2009.10.001. Epub 2009 Oct 25. Complement Ther Clin Pract. 2010. PMID: 20129411 Review.
-
Critical review of complementary therapies for prostate cancer.J Clin Oncol. 2003 Jun 1;21(11):2199-210. doi: 10.1200/JCO.2003.08.083. J Clin Oncol. 2003. PMID: 12775747 Review.
Cited by
-
Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors.Oncol Nurs Forum. 2007 Mar;34(2):359-64. doi: 10.1188/07.ONF.359-364. Oncol Nurs Forum. 2007. PMID: 17573300 Free PMC article.
-
Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia.J Altern Complement Med. 2011 May;17(5):469-72. doi: 10.1089/acm.2010.0300. Epub 2011 May 9. J Altern Complement Med. 2011. PMID: 21554128 Free PMC article. Clinical Trial.
-
Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study.Am J Hematol. 2009 Dec;84(12):795-8. doi: 10.1002/ajh.21554. Am J Hematol. 2009. PMID: 19894247 Free PMC article.
-
Complementary and alternative medicine (CAM) in Mexican patients with cancer.Clin Transl Oncol. 2006 Mar;8(3):200-7. doi: 10.1007/s12094-006-0011-2. Clin Transl Oncol. 2006. PMID: 16648120 Review.
-
Complementary and alternative medicine use among newly diagnosed prostate cancer patients.Support Care Cancer. 2012 Jan;20(1):65-73. doi: 10.1007/s00520-010-1055-y. Epub 2010 Dec 1. Support Care Cancer. 2012. PMID: 21120540
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical